ASX-listed shares of Hera Med jump most in 3 months on strategic partnership

Heramed

13/03/2024 03:19

** Shares of ASX listed Hera Med  HMD.AX  rise as much as
15% to A$0.023, their biggest intraday pct gain since Dec 18,
2023
    ** Stock posts its highest level since Feb 28
    ** The pregnancy monitoring solution provider has signed a
binding agreement with U.S.-based maternal solutions
organization, FemBridge, to develop a scalable maternal health
solution
    ** "We anticipate achieving commercial milestones in the
immediate future, with a steady growth trajectory expected
throughout the remainder of 2024," say co-founders Traci Quillen
and Maggie Huether
    ** About 911,410 shares change hands, compared with the
30-day average volume of 258,305 shares
    ** Stock down 0.9% so far this year, as of last close
    

 (Reporting by Megha  Rani)
 ((Megha.Rani2@thomsonreuters.com;))